This Pharma stock engaged in providing Ayurveda-based healthcare services, operating hospitals, clinics, and wellness centers across India with a wide range of treatments, jumped 5 percent after the company’s board approved the stock split in a 1:5 ratio.
Stock Price Movement
With a market capitalization of Rs. 5,771.28 crores, the share of Jeena Sikho Lifecare Limited has reached an intraday high of Rs. 2,351.95 per equity share, rising nearly 4.5 percent from its previous day’s close price of Rs. 2,251.25. Since then, the stock has retreated and is currently trading at Rs. 2,321.50 per equity share.
What is the news?
On 21st April 2025, the Board of Directors of Jeena Sikho Lifecare Limited approved the sub-division of the company’s existing equity shares. One fully paid-up equity share with a face value of Rs. 10 each will be split into five fully paid-up shares of Rs. 2 each.
Also read: Mukesh Ambani stock skyrockets 14% after reporting 38% YoY net profit growth in Q4
Service Offerings
Jeena Sikho Lifecare Limited offers a range of services, including in-patient and out-patient care, Panchakarma therapies, diet plans, medical kits, health counseling through a contact center, and health camps. Its clinics and hospitals operate under names like Shuddhi Ayurveda, HiiMS, and Shuddhi Wellness Clinics & Hospital.
Business Overview
Jeena Sikho Lifecare Limited is one of India’s leading providers of Ayurveda-based healthcare services. The company operates 36 hospitals, 74 clinics, and daycare centers, with a total of 1,530 beds, and plans to add 518 more.
The company serves over 100 cities and towns across 21 states. The company offers more than 350 different Ayurvedic medicines, providing a wide range of healthcare solutions to its patients.
Recent quarter results
Jeena Sikho Lifecare Limited’s revenue has increased from Rs. 157 crore in H1 FY24 to Rs. 214 crore in H1 FY25, which has grown by 36.31 percent. The net profit has also grown by 46.88 percent, from Rs. 32 crore in H1 FY24 to Rs. 47 crore in H1 FY25.
Written By – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
